Clinical Trials Logo

Clinical Trial Summary

Study Description The goal of this observational study is to detect intestinal flora and the metabolic products in premature infants diagnosed as necrotizing enterocolitis. The main questions it aims to answer are: - 1. Whether there is intestinal flora in the stool of premature infants. - 2. Are there dysregulated intestinal flora and their metabolic products in premature infants diagnosed as necrotizing enterocolitis. - 3. The detailed role and underlying mechanism of the intestinal dysbacteriosis and the metabolic products in premature infants diagnosed as necrotizing enterocolitis. Participants, premature infants diagnosed as necrotizing enterocolitis (NEC group), will be asked to collect stool (usually 2 times) for intestinal flora analysis. If there is a comparison group: Researchers will compare premature infants without necrotizing enterocolitis (control group) to see if their intestinal flora and the metabolic products also changed as their NEC counterparts.


Clinical Trial Description

When the patients is hospitalized in neonatology, we screen the premature infants according to the selection criteria and exclusion criteria. After sighed the informed consent, they are classified into two groups: premature infants diagnosed as necrotizing enterocolitis (NEC group) and premature infants without necrotizing enterocolitis (control group). Their stool and blood (usually 2 times ) are collected for intestinal flora and FABP (including L-FABP and I-FABP) analysis, respectively. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05619055
Study type Observational
Source Qianfoshan Hospital
Contact Zuohui Zhao, Dr
Phone 0086-531-89268509
Email zhaozuohui@126.com
Status Recruiting
Phase
Start date November 5, 2022
Completion date March 31, 2025

See also
  Status Clinical Trial Phase
Completed NCT03926390 - Gut Priming With Oral Bovine Colostrum for Preterm Neonates; Randomized Control Trial N/A
Completed NCT03111329 - Does Routine Assessment of Gastric Residuals in Preterm Neonates Influence Time Taken to Reach Full Enteral Feeding? N/A
Recruiting NCT03549507 - CEUS Evaluation of Bowel Perfusion in Necrotizing Enterocolitis Phase 3
Completed NCT04977817 - Probiotics/TPN in the NICU
Completed NCT03136172 - Monitoring of Systemic or Organ Perfusion for Preterm Infants
Completed NCT04719546 - Risk Factors of Necrotizing Enterocolitis in Premature Newborns
Recruiting NCT03366584 - The Effect of β-Carotene, Vitamin D3 and Zinc on Hyaline Membrane Disease and Feeding Intolerance in Premature Neonates Phase 4
Recruiting NCT04083638 - The Relationship Between Erythrocyte Transfusion and Nutrition and Necrotizing Enterocolitis in Preterm Infants
Not yet recruiting NCT05710575 - Role of Probiotic Use in Outcomes of Premature Birth N/A
Recruiting NCT05121753 - Infant Formula Feeding and Necrotizing Enterocolitis in Newborns
Recruiting NCT03997266 - NICU Antibiotics and Outcomes Trial Phase 4